MedPath
NMPA Approval

Urokinase for Injection

国药准字H51021400

March 30, 2021

国药准字H51021400

Drug Information

注射用尿激酶

注射剂(注射用无菌粉末)

150万单位

化学药品

March 30, 2021

Company Information

Applicant Company

成都海峡两岸科技产业开发园柳台大道B段

Manufacturing Company

成都海峡两岸科技产业开发园柳台大道B段

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

注射用尿激酶 - NMPA 批准文号 | MedPath